Title: Successful treatment of refractory warts with topical vitamin D<sub>3</sub> derivative (maxacalcitol, 1α, 25‐dihydroxy‐22‐oxacalcitriol) in 17 patients
Abstract: The Journal of DermatologyVolume 34, Issue 4 p. 264-266 Successful treatment of refractory warts with topical vitamin D3 derivative (maxacalcitol, 1α, 25-dihydroxy-22-oxacalcitriol) in 17 patients Ichiro IMAGAWA, Ichiro IMAGAWA Department of Dermatology, Nihon University School of Medicine, Oyaguchi-Kamimachi, Itabashi-ku, Tokyo, JapanSearch for more papers by this authorHiroyuki SUZUKI, Hiroyuki SUZUKI Department of Dermatology, Nihon University School of Medicine, Oyaguchi-Kamimachi, Itabashi-ku, Tokyo, JapanSearch for more papers by this author Ichiro IMAGAWA, Ichiro IMAGAWA Department of Dermatology, Nihon University School of Medicine, Oyaguchi-Kamimachi, Itabashi-ku, Tokyo, JapanSearch for more papers by this authorHiroyuki SUZUKI, Hiroyuki SUZUKI Department of Dermatology, Nihon University School of Medicine, Oyaguchi-Kamimachi, Itabashi-ku, Tokyo, JapanSearch for more papers by this author First published: 09 March 2007 https://doi.org/10.1111/j.1346-8138.2007.00266.xCitations: 22 Dr Hiroyuki Suzuki, 4-3-18 Naka-Aoki, Kawaguchi, Satitama, 332-0032 Japan. Email: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Sterling JC, Handfield-Jones S, Hudson PM. Guidelines for the management of cutaneous warts. Br J Dermatol 2001; 144: 4–11. 2 Gibbs S, Harvey I, Sterling J, Stark R. Local treatments for cutaneous warts: systematic review. Br Med J 2002; 325: 461–464. 3 Allam J-P, Hagemann T, Bieber T, Novak N. Successful treatment of therapy-resistant plantar verrucae vulgaris with systemic interferon-beta. J Dermatol 2004; 31: 582–583. 4 Egawa K, Ono T. Topical vitamin D3 derivatives for recalcitrant warts in three immunocompromised patients. Br J Dermatol 2004; 150: 374–376. 5 Barker JNWN, Ashton RE, Marks R, Harris RI, Berth-Jones J. Topical maxacalcitol for treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator. Br J Dermatol 1999; 142: 274–278. 6 Gupta AK, Browne M, Bluhm R. Nonpsoriatic uses of calcipotriol. J Cuta Med Surg 2002: 6: 442–448. 7 Kragballe K, Steijlen PM, Ibsen HH et al. Efficacy, tolerability, and safety of calcipotriol onintment in disorders of keratinization. Arch Dermatol 1995: 131: 556–560. 8 Lebwohl M. Psoriasis. Lancet 2003; 361: 1197–1204. 9 Ogino FM, Sato Y, Ohta H et al. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacacitol). Br J Dermatol 1998: 138: 63–70. 10 Fukuya Y, Higaki M, Higaki Y, Kawashima M. Effect of vitamin D3 on the increased expression of Bcl-xL inpsoriasis. Arch Dermatol Res 2002; 293: 620–625. 11 Ameen M, Chu AC. Treatment of vitiligo with topical calcipotriol. Br J Dermatol 1999; 141: 75. Citing Literature Volume34, Issue4April 2007Pages 264-266 ReferencesRelatedInformation
Publication Year: 2007
Publication Date: 2007-03-09
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 31
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot